HEADER TRANSFERASE/TRANSFERASE INHIBITOR 17-SEP-04 1XHA TITLE CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX TITLE 2 WITH PROTEIN KINASE A AND MUTANTS CAVEAT 1XHA R68 A 1001 HAS WRONG CHIRALITY AT ATOM C91 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PROTEIN KINASE A, PKA C-ALPHA; COMPND 5 EC: 2.7.1.37; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE INHIBITOR, ALPHA FORM; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: PKI(RESIDUES 5-24); COMPND 12 SYNONYM: PROTEIN KINASE INHIBITOR PEPTIDE; PKI-ALPHA; CAMP-DEPENDENT COMPND 13 PROTEIN KINASE INHIBITOR, MUSCLE/BRAIN ISOFORM; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: CATTLE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 GENE: PRKACA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21DE3; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET29B; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 14 ORGANISM_TAXID: 32630; SOURCE 15 OTHER_DETAILS: PEPTIDE SYNTHESIS KEYWDS PKA, KINASE-INHIBITOR-COMPLEX, SERINE/THREONINE-PROTEIN KINASE, KEYWDS 2 BALANOL DERIVATIVE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.B.BREITENLECHNER,W.-G.FRIEBE,E.BRUNET,G.WERNER,K.GRAUL,U.THOMAS,K.- AUTHOR 2 P.KUENKELE,W.SCHAEFER,M.GASSEL,D.BOSSEMEYER,R.HUBER,R.A.ENGH, AUTHOR 3 B.MASJOST REVDAT 5 16-OCT-24 1XHA 1 REMARK REVDAT 4 26-JUN-24 1XHA 1 CAVEAT SOURCE REMARK REVDAT 3 10-NOV-21 1XHA 1 REMARK SEQADV LINK REVDAT 2 24-FEB-09 1XHA 1 VERSN REVDAT 1 17-SEP-05 1XHA 0 JRNL AUTH C.B.BREITENLECHNER,W.-G.FRIEBE,E.BRUNET,G.WERNER,K.GRAUL, JRNL AUTH 2 U.THOMAS,K.-P.KUENKELE,W.SCHAEFER,M.GASSEL,D.BOSSEMEYER, JRNL AUTH 3 R.HUBER,R.A.ENGH,B.MASJOST JRNL TITL DESIGN AND CRYSTAL STRUCTURES OF PROTEIN KINASE B-SELECTIVE JRNL TITL 2 INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS JRNL REF J.MED.CHEM. V. 48 163 2005 JRNL REFN ISSN 0022-2623 JRNL PMID 15634010 JRNL DOI 10.1021/JM049701N REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.B.BREITENLECHNER,T.WEGGE,L.BERILLON,K.GRAUL,K.MARZENELL, REMARK 1 AUTH 2 W.-G.FRIEBE,U.THOMAS,R.SCHUMACHER,R.HUBER,R.A.ENGH,B.MASJOST REMARK 1 TITL STRUCTURE-BASED OPTIMIZATION OF NOVEL AZEPANE DERIVATIVES AS REMARK 1 TITL 2 PKB INHIBITORS REMARK 1 REF J.MED.CHEM. V. 47 1375 2004 REMARK 1 REFN ISSN 0022-2623 REMARK 1 PMID 14998327 REMARK 1 DOI 10.1021/JM0310479 REMARK 2 REMARK 2 RESOLUTION. 2.46 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.46 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 16210 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.223 REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 866 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.46 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.52 REMARK 3 REFLECTION IN BIN (WORKING SET) : 905 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2510 REMARK 3 BIN FREE R VALUE SET COUNT : 51 REMARK 3 BIN FREE R VALUE : 0.3660 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2983 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 43 REMARK 3 SOLVENT ATOMS : 48 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.23000 REMARK 3 B22 (A**2) : -1.63000 REMARK 3 B33 (A**2) : 0.40000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.493 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.299 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.234 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.534 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.919 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.887 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3103 ; 0.015 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 2741 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4196 ; 1.428 ; 1.962 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6372 ; 0.851 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 368 ; 6.438 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 435 ; 0.083 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3446 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 667 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 625 ; 0.202 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3097 ; 0.227 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 1775 ; 0.086 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 80 ; 0.167 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 11 ; 0.195 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 39 ; 0.202 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 6 ; 0.269 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1837 ; 0.597 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2943 ; 1.126 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1266 ; 1.503 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1253 ; 2.486 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 1XHA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 21-SEP-04. REMARK 100 THE DEPOSITION ID IS D_1000030359. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-FEB-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MPG/DESY, HAMBURG REMARK 200 BEAMLINE : BW6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.05 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17086 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.460 REMARK 200 RESOLUTION RANGE LOW (A) : 65.938 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.67 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: LICL, MESBISTRIS, METHANOL, MEGA-8, PH REMARK 280 6.4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 278K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.92100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 58.66450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.78600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 58.66450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.92100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.78600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3260 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16690 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 8 CG CD CE NZ REMARK 470 LYS A 16 CG CD CE NZ REMARK 470 LEU A 198 CG CD1 CD2 REMARK 470 LYS A 217 CE NZ REMARK 470 LYS A 285 CG CD CE NZ REMARK 470 LYS A 309 CG CD CE NZ REMARK 470 LYS A 317 CB CG CD CE NZ REMARK 470 PHE A 318 CB CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 319 CB CG CD CE NZ REMARK 470 LYS A 345 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ARG B 15 O HOH B 1 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 45 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 ASP A 75 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 ARG A 144 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ASP A 301 CB - CG - OD2 ANGL. DEV. = 6.6 DEGREES REMARK 500 ASP B 9 CB - CG - OD2 ANGL. DEV. = 6.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 10 -42.00 -157.29 REMARK 500 ASN A 32 71.08 -160.01 REMARK 500 ALA A 38 -161.56 -165.66 REMARK 500 ASN A 99 110.19 -165.69 REMARK 500 ASP A 166 45.59 -148.56 REMARK 500 LYS A 168 149.54 171.31 REMARK 500 ASP A 184 71.29 64.53 REMARK 500 LYS A 217 -41.47 -28.45 REMARK 500 ALA A 240 156.93 175.77 REMARK 500 LEU A 273 49.79 -88.33 REMARK 500 PRO A 313 9.51 -65.70 REMARK 500 PHE A 314 101.14 -168.61 REMARK 500 LYS A 319 42.20 -79.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE R68 A 1001 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1SVH RELATED DB: PDB REMARK 900 PROTEIN KINASE A COMPLEXED WITH AZEPANE DERIVATIVE 8 REMARK 900 RELATED ID: 1SVE RELATED DB: PDB REMARK 900 PROTEIN KINASE A COMPLEXED WITH AZEPANE DERIVATIVE 1 REMARK 900 RELATED ID: 1SVG RELATED DB: PDB REMARK 900 PROTEIN KINASE A COMPLEXED WITH AZEPANE DERIVATIVE 4 REMARK 900 RELATED ID: 1VEB RELATED DB: PDB REMARK 900 PROTEIN KINASE A COMPLEXED WITH AZEPANE DERIVATIVE 5 REMARK 900 RELATED ID: 1XH4 RELATED DB: PDB REMARK 900 PROTEIN KINASE A COMPLEXED WITH ATP COMPETITIVE INHIBITOR COMPOUND 1 REMARK 900 RELATED ID: 1XH5 RELATED DB: PDB REMARK 900 PROTEIN KINASE A COMPLEXED WITH ATP COMPETITIVE INHIBITOR COMPOUND 2 REMARK 900 RELATED ID: 1XH6 RELATED DB: PDB REMARK 900 PROTEIN KINASE A COMPLEXED WITH ATP COMPETITIVE INHIBITOR COMPOUND 3 REMARK 900 RELATED ID: 1XH7 RELATED DB: PDB REMARK 900 PROTEIN KINASE A COMPLEXED WITH ATP COMPETITIVE INHIBITOR COMPOUND 4 REMARK 900 RELATED ID: 1XH8 RELATED DB: PDB REMARK 900 PROTEIN KINASE A COMPLEXED WITH ATP COMPETITIVE INHIBITOR COMPOUND 5 REMARK 900 RELATED ID: 1XH9 RELATED DB: PDB REMARK 900 PROTEIN KINASE A(Q84E,V123A,L173M,F187L,Q181K) COMPLEXED WITH ATP REMARK 900 COMPETITIVE INHIBITOR COMPOUND 1 DBREF 1XHA A 1 350 UNP P00517 KAPCA_BOVIN 1 350 DBREF 1XHA B 5 24 UNP P61925 IPKA_HUMAN 5 24 SEQADV 1XHA GLU A 84 UNP P00517 GLN 84 ENGINEERED MUTATION SEQADV 1XHA ALA A 123 UNP P00517 VAL 123 ENGINEERED MUTATION SEQADV 1XHA MET A 173 UNP P00517 LEU 173 ENGINEERED MUTATION SEQADV 1XHA LEU A 187 UNP P00517 PHE 187 ENGINEERED MUTATION SEQADV 1XHA TPO A 197 UNP P00517 THR 197 MODIFIED RESIDUE SEQADV 1XHA SEP A 338 UNP P00517 SER 338 MODIFIED RESIDUE SEQRES 1 A 350 GLY ASN ALA ALA ALA ALA LYS LYS GLY SER GLU GLN GLU SEQRES 2 A 350 SER VAL LYS GLU PHE LEU ALA LYS ALA LYS GLU ASP PHE SEQRES 3 A 350 LEU LYS LYS TRP GLU ASN PRO ALA GLN ASN THR ALA HIS SEQRES 4 A 350 LEU ASP GLN PHE GLU ARG ILE LYS THR LEU GLY THR GLY SEQRES 5 A 350 SER PHE GLY ARG VAL MET LEU VAL LYS HIS MET GLU THR SEQRES 6 A 350 GLY ASN HIS TYR ALA MET LYS ILE LEU ASP LYS GLN LYS SEQRES 7 A 350 VAL VAL LYS LEU LYS GLU ILE GLU HIS THR LEU ASN GLU SEQRES 8 A 350 LYS ARG ILE LEU GLN ALA VAL ASN PHE PRO PHE LEU VAL SEQRES 9 A 350 LYS LEU GLU PHE SER PHE LYS ASP ASN SER ASN LEU TYR SEQRES 10 A 350 MET VAL MET GLU TYR ALA PRO GLY GLY GLU MET PHE SER SEQRES 11 A 350 HIS LEU ARG ARG ILE GLY ARG PHE SER GLU PRO HIS ALA SEQRES 12 A 350 ARG PHE TYR ALA ALA GLN ILE VAL LEU THR PHE GLU TYR SEQRES 13 A 350 LEU HIS SER LEU ASP LEU ILE TYR ARG ASP LEU LYS PRO SEQRES 14 A 350 GLU ASN LEU MET ILE ASP GLN GLN GLY TYR ILE GLN VAL SEQRES 15 A 350 THR ASP PHE GLY LEU ALA LYS ARG VAL LYS GLY ARG THR SEQRES 16 A 350 TRP TPO LEU CYS GLY THR PRO GLU TYR LEU ALA PRO GLU SEQRES 17 A 350 ILE ILE LEU SER LYS GLY TYR ASN LYS ALA VAL ASP TRP SEQRES 18 A 350 TRP ALA LEU GLY VAL LEU ILE TYR GLU MET ALA ALA GLY SEQRES 19 A 350 TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE GLN ILE TYR SEQRES 20 A 350 GLU LYS ILE VAL SER GLY LYS VAL ARG PHE PRO SER HIS SEQRES 21 A 350 PHE SER SER ASP LEU LYS ASP LEU LEU ARG ASN LEU LEU SEQRES 22 A 350 GLN VAL ASP LEU THR LYS ARG PHE GLY ASN LEU LYS ASN SEQRES 23 A 350 GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP PHE ALA THR SEQRES 24 A 350 THR ASP TRP ILE ALA ILE TYR GLN ARG LYS VAL GLU ALA SEQRES 25 A 350 PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY ASP THR SER SEQRES 26 A 350 ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE ARG VAL SEP SEQRES 27 A 350 ILE ASN GLU LYS CYS GLY LYS GLU PHE SER GLU PHE SEQRES 1 B 20 THR THR TYR ALA ASP PHE ILE ALA SER GLY ARG THR GLY SEQRES 2 B 20 ARG ARG ASN ALA ILE HIS ASP MODRES 1XHA TPO A 197 THR PHOSPHOTHREONINE MODRES 1XHA SEP A 338 SER PHOSPHOSERINE HET TPO A 197 11 HET SEP A 338 10 HET R68 A1001 43 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM R68 N-{4-[(4-{3-[(2R)-3,3-DIMETHYLPIPERIDIN-2-YL]-2-FLUORO- HETNAM 2 R68 6-HYDROXYBENZOYL}BENZOYL)AMINO]AZEPAN-3- HETNAM 3 R68 YL}ISONICOTINAMIDE HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE FORMUL 1 TPO C4 H10 N O6 P FORMUL 1 SEP C3 H8 N O6 P FORMUL 3 R68 C33 H38 F N5 O4 FORMUL 4 HOH *48(H2 O) HELIX 1 1 GLY A 1 GLU A 31 1 31 HELIX 2 2 HIS A 39 ASP A 41 5 3 HELIX 3 3 LYS A 76 LEU A 82 1 7 HELIX 4 4 GLU A 84 VAL A 98 1 15 HELIX 5 5 GLU A 127 GLY A 136 1 10 HELIX 6 6 SER A 139 LEU A 160 1 22 HELIX 7 7 LYS A 168 GLU A 170 5 3 HELIX 8 8 THR A 201 LEU A 205 5 5 HELIX 9 9 ALA A 206 LEU A 211 1 6 HELIX 10 10 LYS A 217 GLY A 234 1 18 HELIX 11 11 GLN A 242 GLY A 253 1 12 HELIX 12 12 SER A 262 LEU A 273 1 12 HELIX 13 13 VAL A 288 ASN A 293 1 6 HELIX 14 14 HIS A 294 ALA A 298 5 5 HELIX 15 15 ASP A 301 GLN A 307 1 7 HELIX 16 16 THR B 5 ALA B 12 1 8 SHEET 1 A 5 PHE A 43 GLY A 52 0 SHEET 2 A 5 GLY A 55 HIS A 62 -1 O LEU A 59 N LYS A 47 SHEET 3 A 5 ASN A 67 ASP A 75 -1 O ILE A 73 N ARG A 56 SHEET 4 A 5 ASN A 115 GLU A 121 -1 O MET A 118 N LYS A 72 SHEET 5 A 5 LEU A 106 LYS A 111 -1 N GLU A 107 O VAL A 119 SHEET 1 B 2 LEU A 162 ILE A 163 0 SHEET 2 B 2 LYS A 189 ARG A 190 -1 O LYS A 189 N ILE A 163 SHEET 1 C 2 LEU A 172 ILE A 174 0 SHEET 2 C 2 ILE A 180 VAL A 182 -1 O GLN A 181 N MET A 173 LINK C TRP A 196 N TPO A 197 1555 1555 1.32 LINK C TPO A 197 N LEU A 198 1555 1555 1.33 LINK C VAL A 337 N SEP A 338 1555 1555 1.33 LINK C SEP A 338 N ILE A 339 1555 1555 1.34 SITE 1 AC1 22 GLY A 50 THR A 51 GLY A 52 SER A 53 SITE 2 AC1 22 PHE A 54 VAL A 57 ALA A 70 LYS A 72 SITE 3 AC1 22 LEU A 74 GLU A 84 GLU A 91 GLU A 121 SITE 4 AC1 22 ALA A 123 GLU A 127 GLU A 170 ASN A 171 SITE 5 AC1 22 MET A 173 THR A 183 ASP A 184 GLY A 186 SITE 6 AC1 22 LEU A 187 PHE A 327 CRYST1 49.842 79.572 117.329 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020063 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012567 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008523 0.00000